Major Adverse Cardiovascular Events and Prognosis in Patients With Coronary Slow Flow

Prior research has shown that coronary slow flow (CSF) is a rare phenomenon observed in coronary angiography. It was already known that CSF is associated with chest discomfort and abnormal hemodynamic parameters. However, the long-term clinical implications of CSF remained unclear. No prior work had resolved whether CSF independently predicts major adverse cardiovascular events (MACEs). This gap motivated the need to evaluate the prognosis and risk profile of CSF patients. The study sought to compare clinical characteristics and outcomes between CSF and control groups. Understanding these differences could clarify the role of CSF in cardiovascular risk. The question of whether CSF is a marker of poor prognosis remained unanswered until this analysis.

The aim was to assess the clinical significance of CSF in predicting cardiovascular outcomes. The specific problem addressed was the lack of clarity regarding the long-term risks associated with CSF. The motivation stemmed from the observation that CSF patients often present with atypical symptoms. The study focused on comparing clinical features and event rates between CSF and normal coronary groups. The researchers propose that CSF may be a risk factor for MACEs. The study sought to determine if CSF independently predicts adverse outcomes. The goal was to evaluate survival curves and hazard ratios for MACEs. The findings could inform clinical management of patients with CSF.

The study compared two groups: 614 patients with CSF and 428 with normal coronary arteries. Clinical and demographic data were collected and analyzed. The incidence of CSF was calculated as 2.65%. Variables such as sex, chest tightness, hyperlipidemia, and lifestyle factors were compared. Statistical analysis included hazard ratios and confidence intervals for MACEs. Kaplan-Meier survival curves were used to evaluate event-free survival. The researchers propose that differences in baseline characteristics may influence outcomes. The study design allowed for multivariate analysis of prognostic factors.

CSF was found to be an independent predictor of MACEs with a hazard ratio of 1.531. The 95% confidence interval ranged from 1.064 to 2.202. The p-value of 0.022 indicated statistical significance. Patients with CSF had a higher incidence of MACEs compared to controls. The Kaplan-Meier analysis showed worse survival outcomes for CSF patients. Clinical differences included higher rates of chest tightness and hyperlipidemia. Smoking and alcohol consumption were more common in the CSF group. These findings suggest that CSF is associated with an increased risk of cardiovascular events.

The authors propose that CSF is a significant risk factor for MACEs. The study suggests that CSF patients have worse clinical outcomes compared to controls. The findings indicate that CSF may serve as a prognostic marker for cardiovascular events. The researchers propose that CSF should be considered in risk stratification models. The study suggests that CSF is linked to traditional risk factors like hyperlipidemia. The results highlight the importance of monitoring CSF patients for MACEs. The authors suggest that further research is needed to clarify the mechanisms of CSF. The study supports the need for targeted interventions in patients with CSF.